Why is Dr Lal Pathlabs falling/rising?

As of 23-Jul, Dr Lal Pathlabs Ltd's stock price is currently at 3,013.00, reflecting an increase of 21.5 (0.72%). The stock has been gaining for the last two days, with a total return of 1.21% during this period. However, it underperformed its sector by 0.66% today. The stock is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend. Despite this, there has been a decline in investor participation, as the delivery volume has fallen by 27.87% compared to the 5-day average. While the company shows strong management efficiency with a high return on equity (ROE) of 20.50% and significant growth in profit after tax (PAT) over the last six months, it also faces risks such as poor long-term growth and consistent underperformance against benchmarks over the past year.
In the broader market context, Dr Lal Pathlabs has outperformed the Sensex in the short term, with a 1-week return of 0.99% compared to the benchmark's 0.11%. However, its year-to-date performance is lagging behind the Sensex, with a return of 0.77% against the benchmark's 5.87%. This suggests that while the stock is experiencing a recent uptick, its overall performance relative to the market remains a concern, particularly given its historical underperformance over the last three years. The stock's valuation is considered expensive, and despite high institutional holdings, the long-term growth prospects appear limited, which could impact investor sentiment moving forward.